{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:07:18Z","timestamp":1790809638208,"version":"4.1.0"},"reference-count":278,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1111\/bjd.19675","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T18:38:23Z","timestamp":1605119903000},"page":"36-51","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identifying and appraising patient\u2010reported outcome measures on treatment satisfaction in acne: a systematic review*"],"prefix":"10.1093","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-0182","authenticated-orcid":false,"given":"E.J.","family":"van Zuuren","sequence":"first","affiliation":[{"name":"Dermatology Department Leiden University Medical Centre Leidenthe Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6884-8014","authenticated-orcid":false,"given":"B.W.M.","family":"Arents","sequence":"additional","affiliation":[{"name":"Skin Patients Netherlands (Huidpati\u00ebnten Nederland) Nieuwegein the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Miklas","sequence":"additional","affiliation":[{"name":"Windsor Clinical Research Inc. Windsor ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Schoones","sequence":"additional","affiliation":[{"name":"Walaeus Library Leiden University Medical Centre Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-4530","authenticated-orcid":false,"given":"J.","family":"Tan","sequence":"additional","affiliation":[{"name":"Windsor Clinical Research Inc. Windsor ON Canada"},{"name":"Western University London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,28]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-13-132"},{"key":"e_1_2_6_3_1","unstructured":"COSMIN.I\u2019m developing a core outcome set (COS). Available at:https:\/\/www.cosmin.nl\/finding\u2010right\u2010tool\/developing\u2010core\u2010outcome\u2010set\/(last accessed 30 June 2020)."},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","unstructured":"MokkinkLB PrinsenCA PatrickDLet al.COSMIN methodology for systematic reviews of patient\u2010reported outcome measures (PROMs). Available at:https:\/\/www.cosmin.nl\/wp\u2010content\/uploads\/COSMIN\u2010syst\u2010review\u2010for\u2010PROMs\u2010manual_version\u20101_feb\u20102018.pdf(last accessed 30 June 2020).","DOI":"10.1007\/978-3-319-69909-7_2972-2"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120912"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-012-0016-8"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.04.017"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2004.72252.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-018-1798-3"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-009-9528-5"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-017-1765-4"},{"key":"e_1_2_6_13_1","first-page":"9","article-title":"Acne treatments come out a wash","volume":"77","author":"Anonymous","year":"2012","journal-title":"Consum Rep"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12751"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20175273"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2003.tb00437.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20886"},{"key":"e_1_2_6_18_1","first-page":"5","article-title":"Current concepts in the treatment of acne: report from a clinical roundtable","volume":"72","author":"Berson DS","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-010-1073-0"},{"key":"e_1_2_6_20_1","first-page":"577","article-title":"Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases","volume":"12","author":"Boehncke W\u2010H","year":"2002","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2007.33174.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546630903089650"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.00759.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000246134"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12061"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2009.00427.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200607020-00003"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2017.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30053.x"},{"key":"e_1_2_6_30_1","first-page":"178","article-title":"Informative flashcards to increase therapy compliance in acne patients receiving adapalene 0.1%\/benzoyl peroxide 2.5%","volume":"18","author":"Fabbrocini G","year":"2016","journal-title":"Esper Dermatol"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2008.00239.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03291.x"},{"key":"e_1_2_6_33_1","first-page":"16","article-title":"New therapy update \u2013 a unique combination formulation in the treatment of inflammatory acne","volume":"72","author":"Fagundes DS","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_6_34_1","first-page":"919","article-title":"Digital videography assessment of patients experiences using adapalene\u2010benzoyl peroxide gel in the treatment of acne vulgaris","volume":"11","author":"Feldman SR","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767120-00007"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1996.tb00608.x"},{"key":"e_1_2_6_37_1","first-page":"S4","article-title":"Clinical evaluation of the SmartSkin fractional laser for the treatment of photodamage and acne scars","volume":"8","author":"Gold MH","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20617"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2010.00969.x"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.029"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03350.x"},{"key":"e_1_2_6_42_1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/ddg.12889","article-title":"Azelaic acid 20 % cream: effects on quality of life and disease severity in adult female acne patients","volume":"14","author":"Kainz JT","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2010.01340.x"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2010.00526.x"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.10.1279"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0254-6272(17)30326-6"},{"key":"e_1_2_6_47_1","first-page":"1121","article-title":"Development of a new patient\u2010reported outcome measure to evaluate treatments for acne and acne scarring: the ACNE\u2010Q","volume":"181","author":"Klassen AF","year":"2019","journal-title":"Br J Dermatol"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2005.tb00739.x"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/095466300750163708"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2010.01686.x"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2006.12.451"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12465"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20276"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2006.02183.x"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.homp.2013.12.002"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1159\/000332847"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1997.tb03787.x"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2017.08.016"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.10.978"},{"key":"e_1_2_6_60_1","first-page":"913","article-title":"Acne in Bulgaria and Greece: comparison study of patient adherence","volume":"76","author":"Petkova VB","year":"2019","journal-title":"Acta Pol Pharm"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.11.1333"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsc.2004.03.002"},{"key":"e_1_2_6_63_1","first-page":"347","article-title":"Handheld LED array device in the treatment of acne vulgaris","volume":"7","author":"Sadick NS","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_64_1","first-page":"115","article-title":"Comparison of topical 5% nicotinamid gel versus 2% clindamycin gel in the treatment of the mild\u2010moderate acne vulgaris: a double\u2010blinded randomized clinical trial","volume":"18","author":"Shahmoradi Z","year":"2013","journal-title":"J Res Med Sci"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-014-0063-y"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22533"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2009.01244.x"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1606096"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1484876"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S20543"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.4103\/jdds.jdds_71_19"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S230921"},{"key":"e_1_2_6_73_1","first-page":"41","article-title":"Adapalene gel 0.1% is effective and well tolerated in acne patients in a dermatology practice setting","volume":"68","author":"Baker M","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12418"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2005.31205"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2011.643221"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1080\/20786204.2009.10873897"},{"key":"e_1_2_6_78_1","first-page":"5","article-title":"The results of the MORE trial: overview","volume":"78","author":"Campbell JL","year":"2006","journal-title":"Cutis"},{"key":"e_1_2_6_79_1","first-page":"63","article-title":"Persistent acne in adult women: tolerability profile of clindamycin 1% in association with benzoyl peroxide 3% in comparison with tretinoin cream 0.05%","volume":"17","author":"Cardinali C","year":"2015","journal-title":"Esper Dermatol"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546630903401454"},{"key":"e_1_2_6_81_1","unstructured":"International Clinical Trials Registry Platform.Effect of antihistamines in acne along with standard therapy. Available athttp:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2019\/05\/018951(last accessed 31 March 2020)."},{"key":"e_1_2_6_82_1","first-page":"26","article-title":"A 6% benzoyl peroxide foaming cloth cleanser used in the treatment of acne vulgaris","volume":"2","author":"Del Rosso JQ","year":"2009","journal-title":"Clin Aesthet Dermatol"},{"key":"e_1_2_6_83_1","first-page":"264","article-title":"Efficacy and safety of adapalene 0.3%\/benzoyl peroxide 2.5% gel plus oral doxycycline in subjects with severe inflammatory acne who are candidates for oral isotretinoin","volume":"17","author":"Del Rosso JQ","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2015.06.007"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1159\/000502575"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04416.x"},{"key":"e_1_2_6_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-018-0352-y"},{"key":"e_1_2_6_88_1","first-page":"514","article-title":"Patient\u2010reported outcomes in acne patients with skin of color using adapalene 0.3%\u2010benzoyl peroxide 2.5%: a prospective real\u2010world study","volume":"18","author":"DuBois J","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13744"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.2165\/11530630-000000000-00000"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2009.07155_supp.x"},{"key":"e_1_2_6_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23099"},{"key":"e_1_2_6_93_1","first-page":"639","article-title":"Efficacy of a novel combination of pneumatic energy and broadband light for the treatment of acne","volume":"7","author":"Gold MH","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_94_1","first-page":"44","article-title":"A New, once\u2010daily, optimized, fixed combination of clindamycin phosphate 1.2% and low\u2010concentration benzoyl peroxide 2.5% gel for the treatment of moderate\u2010to\u2010severe acne","volume":"2","author":"Gold M","year":"2009","journal-title":"J Clin Aesthetic Dermatol"},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2013.854638"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13195"},{"key":"e_1_2_6_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12013"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.11.027"},{"key":"e_1_2_6_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1998.tb00763.x"},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2013.814464"},{"key":"e_1_2_6_101_1","unstructured":"Iranian Registry of Clinical Trials.The effect of topical semisolid formulation of metformin on severity and number of skin lesions in acne patients (IRCT2017013132319N1). Available at:https:\/\/en.irct.ir\/trial\/25214(last accessed 31 March 2020)."},{"key":"e_1_2_6_102_1","unstructured":"Iranian Registry of Clinical Trials.Spironolactone for adult female acne (ISRCTN12892056). Available at:http:\/\/www.isrctn.com\/ISRCTN12892056(last accessed 31 March 2020)."},{"key":"e_1_2_6_103_1","first-page":"539","article-title":"[Study on the usage of acne patches in patients with acne]","volume":"56","author":"Jung HJ","year":"2018","journal-title":"Korean J Dermatol"},{"key":"e_1_2_6_104_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07047.x"},{"key":"e_1_2_6_105_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.97666"},{"key":"e_1_2_6_106_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1342758"},{"key":"e_1_2_6_107_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764170802071173"},{"key":"e_1_2_6_108_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12788"},{"key":"e_1_2_6_109_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14714"},{"key":"e_1_2_6_110_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001815"},{"key":"e_1_2_6_111_1","first-page":"985","article-title":"Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne","volume":"5","author":"Laquieze S","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05255.x"},{"key":"e_1_2_6_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22200"},{"key":"e_1_2_6_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13631"},{"key":"e_1_2_6_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12962"},{"key":"e_1_2_6_116_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1638"},{"key":"e_1_2_6_117_1","doi-asserted-by":"publisher","DOI":"10.5978\/islsm.12-OR-11"},{"key":"e_1_2_6_118_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764170600999310"},{"key":"e_1_2_6_119_1","first-page":"570","article-title":"A phase 2b, randomized, double\u2010blind vehicle controlled, dose escalation study evaluating clascoterone 0.1%, 0.5%, and 1% topical cream in subjects with facial acne","volume":"18","author":"Mazzetti A","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-015-1601-z"},{"key":"e_1_2_6_121_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2164"},{"key":"e_1_2_6_122_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-016-1639-6"},{"key":"e_1_2_6_123_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05295.x"},{"key":"e_1_2_6_124_1","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9175.180641"},{"key":"e_1_2_6_125_1","doi-asserted-by":"publisher","DOI":"10.4103\/jrpp.JRPP_17_29"},{"key":"e_1_2_6_126_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S115192"},{"key":"e_1_2_6_127_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-017-0203-4"},{"key":"e_1_2_6_128_1","unstructured":"ClinicalTrials.gov.A randomized controlled evaluator\u2010blinded pilot study to evaluate the effect of automated text message reminders on patient compliance with topical medications and its efficacy on skin disease control in adolescents and adults with mild to moderate acne (NCT01082523). Available at:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01082523(last accessed 31 March 2020)."},{"key":"e_1_2_6_129_1","first-page":"328","article-title":"Observational study of clindamycin phosphate and tretinoin gel for the treatment of acne","volume":"18","author":"Ohlson J","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_130_1","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2010.526664"},{"key":"e_1_2_6_131_1","first-page":"1083","article-title":"An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once\u2010daily treatment of moderate to severe acne vulgaris","volume":"13","author":"Pariser DM","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_132_1","first-page":"121","article-title":"Treatment of moderate to severe acne vulgaris with an oral isotretinoin similar to the reference product","volume":"8","author":"Picosse FR","year":"2016","journal-title":"Surg Cosmet Dermatol"},{"key":"e_1_2_6_133_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-015-1816-4"},{"key":"e_1_2_6_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(03)00167-7"},{"key":"e_1_2_6_135_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06078.x"},{"key":"e_1_2_6_136_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP201861"},{"key":"e_1_2_6_137_1","first-page":"231","article-title":"Acne treatment patterns, expectations, and satisfaction among adult females of different races\/ethnicities","volume":"8","author":"Rendon MI","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"e_1_2_6_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14314"},{"key":"e_1_2_6_139_1","first-page":"139","article-title":"Photopneumatic technology for the treatment of acne vulgaris","volume":"7","author":"Shamban AT","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_140_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2012.720023"},{"key":"e_1_2_6_141_1","first-page":"537","article-title":"A study of 5.5% benzoyl peroxide microsphere cream versus 6% benzoyl peroxide gel in the treatment of acne vulgaris","volume":"19","author":"Smith SR","year":"2006","journal-title":"Cosmet Dermatol"},{"key":"e_1_2_6_142_1","doi-asserted-by":"publisher","DOI":"10.1136\/aim.2010.003004"},{"key":"e_1_2_6_143_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20153969"},{"key":"e_1_2_6_144_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0178-4"},{"key":"e_1_2_6_145_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2008.23.6.969"},{"key":"e_1_2_6_146_1","first-page":"174","article-title":"Short\u2010term combination therapy and long\u2010term relapse prevention in the treatment of severe acne vulgaris","volume":"11","author":"Tan J","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_147_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2018.3367"},{"key":"e_1_2_6_148_1","first-page":"542","article-title":"A phase 2, multicenter, double\u2010blind, randomized, vehicle\u2010controlled clinical study to compare the safety and efficacy of a novel tazarotene 0.045% lotion and tazarotene 0.1% cream in the treatment of moderate\u2010to\u2010severe acne vulgaris","volume":"18","author":"Tanghetti EA","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_149_1","first-page":"91","article-title":"Randomized, observer\u2010blind, split\u2010face study to compare the irritation potential of 2 topical acne formulations over a 14\u2010day treatment period","volume":"90","author":"Ting W","year":"2012","journal-title":"Cutis"},{"key":"e_1_2_6_150_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764170600607624"},{"key":"e_1_2_6_151_1","first-page":"17","article-title":"Community study of fixed\u2010combination adapalene 0.1% and benzoyl peroxide 2.5% in acne","volume":"8","author":"Troielli PA","year":"2010","journal-title":"Skinmed"},{"key":"e_1_2_6_152_1","first-page":"1","article-title":"An exploratory study of community pharmacist diagnosis and management of dermatitis and acne","volume":"8","author":"Tucker RP","year":"2017","journal-title":"SelfCare"},{"key":"e_1_2_6_153_1","first-page":"1084","article-title":"Novel tretinoin 0.05% lotion for the once\u2010daily treatment of moderate\u2010to\u2010severe acne vulgaris: assessment of efficacy and safety in patients aged 9 years and older","volume":"17","author":"Tyring SK","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_154_1","first-page":"491","article-title":"Efficacy and tolerability of topical 0.2% Myrtacine(R) and 4% vitamin PP for prevention and treatment of retinoid dermatitis in patients with mild to moderate acne","volume":"147","author":"Veraldi S","year":"2012","journal-title":"G Ital Dermatol Venereol"},{"key":"e_1_2_6_155_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2015.1133880"},{"key":"e_1_2_6_156_1","first-page":"50","article-title":"Results of a multicenter, randomized, controlled trial of a hydrogen peroxide\u2010based kit versus a benzoyl peroxide\u2010based kit in mild\u2010to\u2010moderate acne","volume":"9","author":"Veraldi S","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_157_1","first-page":"3","article-title":"Improving patient satisfaction and acne severity in patients with mild to moderate acne: the BEST study","volume":"71","author":"Weiss JS","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_6_158_1","first-page":"596","article-title":"Evaluation of self\u2010treatment of mild\u2010to\u2010moderate facial acne with a blue light treatment system","volume":"10","author":"Wheeland RG","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_159_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2011.564626"},{"key":"e_1_2_6_160_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1595505"},{"key":"e_1_2_6_161_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamafacial.2018.1404"},{"key":"e_1_2_6_162_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.21092"},{"key":"e_1_2_6_163_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2015.1007067"},{"key":"e_1_2_6_164_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2012.00616.x"},{"key":"e_1_2_6_165_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12981"},{"key":"e_1_2_6_166_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2007.33059.x"},{"key":"e_1_2_6_167_1","first-page":"e7","article-title":"Fractional CO(2) laser treatment vs autologous fat transfer in the treatment of acne scars: a comparative study","volume":"12","author":"Azzam OA","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_168_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.10.1295"},{"key":"e_1_2_6_169_1","doi-asserted-by":"publisher","DOI":"10.1080\/147641701753414942"},{"key":"e_1_2_6_170_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22734"},{"key":"e_1_2_6_171_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2006.32071.x"},{"key":"e_1_2_6_172_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22165"},{"key":"e_1_2_6_173_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000637-200044050-00013"},{"key":"e_1_2_6_174_1","first-page":"377","article-title":"Laser facial resurfacing: patient survey of recovery and results","volume":"29","author":"Brunner E","year":"2000","journal-title":"J Otolaryngol"},{"key":"e_1_2_6_175_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000597"},{"key":"e_1_2_6_176_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764172.2017.1406606"},{"key":"e_1_2_6_177_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.10247"},{"key":"e_1_2_6_178_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20974"},{"key":"e_1_2_6_179_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20659"},{"key":"e_1_2_6_180_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2012.02402.x"},{"key":"e_1_2_6_181_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2008.34284.x"},{"key":"e_1_2_6_182_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-007-0509-z"},{"key":"e_1_2_6_183_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23151"},{"key":"e_1_2_6_184_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22950"},{"key":"e_1_2_6_185_1","first-page":"328","article-title":"[Association of microneedling with phenol peeling: a new therapeutic approach for sagging, wrinkles and acne scars on the face]","volume":"7","author":"Andrade LE","year":"2015","journal-title":"Surg Cosmet Dermatol"},{"key":"e_1_2_6_186_1","first-page":"234","article-title":"[Percutaneous induction of collagen with needles (IPCA) associated with pulsed radiofrequency with multineedles (RFPM) in the management of depressed acne scars: treatment protocol]","volume":"9","author":"Andrade Lima EV","year":"2017","journal-title":"Surg Cosmet Dermatol"},{"key":"e_1_2_6_187_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001689"},{"key":"e_1_2_6_188_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22763"},{"key":"e_1_2_6_189_1","first-page":"41","article-title":"Non\u2010insulated fractional microneedle radiofrequency treatment with smooth motor insertion for reduction of depressed acne scars, pore size, and skin texture improvement: a preliminary study","volume":"11","author":"Elawar A","year":"2018","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_190_1","first-page":"1062","article-title":"Correction of atrophic scars with Artefill: an open\u2010label pilot study","volume":"9","author":"Epstein RE","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_191_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-008-9161-7"},{"key":"e_1_2_6_192_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12346"},{"key":"e_1_2_6_193_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2016.1157354"},{"key":"e_1_2_6_194_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12909"},{"key":"e_1_2_6_195_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12523"},{"key":"e_1_2_6_196_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12311"},{"key":"e_1_2_6_197_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2012.687824"},{"key":"e_1_2_6_198_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1998.tb04225.x"},{"key":"e_1_2_6_199_1","first-page":"138","article-title":"Ablative skin resurfacing with a novel microablative CO2 laser","volume":"8","author":"Gotkin RH","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_200_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22048"},{"key":"e_1_2_6_201_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-010-0801-1"},{"key":"e_1_2_6_202_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2009.01139.x"},{"key":"e_1_2_6_203_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2011.02009.x"},{"key":"e_1_2_6_204_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1365111"},{"key":"e_1_2_6_205_1","first-page":"907","article-title":"Evaluation of clinical improvement in acne scars and active acne in patients treated with the 1540\u2010nm non\u2010ablative fractional laser","volume":"10","author":"Isarr\u00eda MJ","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_206_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764170903134326"},{"key":"e_1_2_6_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.02.034"},{"key":"e_1_2_6_208_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2007.33318.x"},{"key":"e_1_2_6_209_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.DSS.0000452625.01889.c3"},{"key":"e_1_2_6_210_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764172.2017.1343950"},{"key":"e_1_2_6_211_1","first-page":"1116","article-title":"Combined 400\u2013600nm and 800\u20131200nm intense pulsed phototherapy of facial acne vulgaris","volume":"18","author":"Knight JM","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_212_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13952"},{"key":"e_1_2_6_213_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22825"},{"key":"e_1_2_6_214_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.11.883"},{"key":"e_1_2_6_215_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2010.01623.x"},{"key":"e_1_2_6_216_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-018-0231-8"},{"key":"e_1_2_6_217_1","first-page":"1109","article-title":"Safety and Effectiveness of microfocused ultrasound with visualization for the correction of moderate to severe atrophic acne scars","volume":"18","author":"Maas CS","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_218_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2010.01513.x"},{"key":"e_1_2_6_219_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2077.138326"},{"key":"e_1_2_6_220_1","first-page":"890","article-title":"Bipolar radiofrequency in the treatment of dermatologic imperfections: clinicopathological and immunohistochemical aspects","volume":"6","author":"Montesi G","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_221_1","unstructured":"ClinicalTrials.gov.Comparison of treatments for atrophic acne scars (NCT02025088). Available at:https:\/\/clinicaltrials.gov\/show\/NCT02025088(last accessed 4 April 2020)."},{"key":"e_1_2_6_222_1","unstructured":"ClinicalTrials.gov.Restylane silk acne scar efficacy evaluation study (NCT02955381). Available at:https:\/\/clinicaltrials.gov\/show\/NCT02955381(last accessed 4 April 2020)."},{"key":"e_1_2_6_223_1","unstructured":"ClinicalTrials.gov.Comparison between microneedling daycare procedure and tazarotene 0.1% gel local application in acne scarring (NCT03170596). Available at:https:\/\/clinicaltrials.gov\/show\/NCT03170596(last accessed 4 April 2020)."},{"key":"e_1_2_6_224_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.107635"},{"key":"e_1_2_6_225_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20885"},{"key":"e_1_2_6_226_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22321"},{"key":"e_1_2_6_227_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2011.02110.x"},{"key":"e_1_2_6_228_1","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2016.062"},{"key":"e_1_2_6_229_1","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2016.004"},{"key":"e_1_2_6_230_1","first-page":"1359","article-title":"Integrated cooling\u2010vacuum\u2010assisted non\u2010fractional 1540 nm erbium:glass laser is effective in treating acne scars","volume":"15","author":"Politi Y","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_231_1","first-page":"1173","article-title":"Integrated cooling\u2010vacuum\u2010assisted non\u2010fractional 1540\u2010nm erbium:glass laser: a new modality for the simultaneous effective treatment of acne lesions and scars","volume":"17","author":"Politi Y","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_232_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2015.1007070"},{"key":"e_1_2_6_233_1","doi-asserted-by":"publisher","DOI":"10.31879\/rcderm.v31i4.6"},{"key":"e_1_2_6_234_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12827"},{"key":"e_1_2_6_235_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mla.2010.09.001"},{"key":"e_1_2_6_236_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000366"},{"key":"e_1_2_6_237_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30078.x"},{"key":"e_1_2_6_238_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13004"},{"key":"e_1_2_6_239_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2008.34127.x"},{"key":"e_1_2_6_240_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000895"},{"key":"e_1_2_6_241_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-017-0777-3"},{"key":"e_1_2_6_242_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13945"},{"key":"e_1_2_6_243_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22224"},{"key":"e_1_2_6_244_1","doi-asserted-by":"publisher","DOI":"10.1001\/archfaci.6.4.234"},{"key":"e_1_2_6_245_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12275"},{"key":"e_1_2_6_246_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764171003706166"},{"key":"e_1_2_6_247_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14032"},{"key":"e_1_2_6_248_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764172.2016.1188211"},{"key":"e_1_2_6_249_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22063"},{"key":"e_1_2_6_250_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2009.00430.x"},{"key":"e_1_2_6_251_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2015.1063658"},{"key":"e_1_2_6_252_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1001-9294(16)30047-5"},{"key":"e_1_2_6_253_1","first-page":"985","article-title":"Histologic study of depressed acne scars treated with serial high\u2010concentration (95%) trichloroacetic acid","volume":"32","author":"Yug A","year":"2016","journal-title":"Dermatol Surg"},{"key":"e_1_2_6_254_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23177"},{"key":"e_1_2_6_255_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2015.1114638"},{"key":"e_1_2_6_256_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2013.1455"},{"key":"e_1_2_6_257_1","first-page":"643","article-title":"Fitzpatrick skin types and clindamycin phosphate 1.2%\/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne","volume":"11","author":"Callender VD","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_258_1","first-page":"26","article-title":"Subject preferences for acne treatments containing adalapene gel 0.1%: results of the MORE trial","volume":"78","author":"Cook\u2010Bolden","year":"2006","journal-title":"Cutis"},{"key":"e_1_2_6_259_1","first-page":"455","article-title":"Treatment of moderate to severe acne vulgaris in a Hispanic population: a post\u2010hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%\/benzoyl peroxide 2.5% gel","volume":"11","author":"Cook\u2010Bolden FE","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_260_1","first-page":"18","article-title":"The BEST study: evaluating efficacy by selected demographic subsets","volume":"71","author":"Fernandez\u2010Obregon A","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_6_261_1","first-page":"152","article-title":"Efficacy and tolerability of fixed\u2010combination acne treatment in adolescents","volume":"91","author":"Gold LS","year":"2013","journal-title":"Cutis"},{"key":"e_1_2_6_262_1","first-page":"5","article-title":"Study design and selection criteria in the BEST study","volume":"71","author":"Rist T","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_6_263_1","first-page":"27","article-title":"The BEST study: results according to prior treatment","volume":"71","author":"Rodriguez D","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_6_264_1","first-page":"35","article-title":"Implications of the BEST study","volume":"71","author":"Shavin J","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_6_265_1","first-page":"10","article-title":"Overall results of the BEST study following treatment of patients with mild to moderate acne","volume":"71","author":"Weiss J","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_6_266_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80073-X"},{"key":"e_1_2_6_267_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-7310(04)76865-9"},{"key":"e_1_2_6_268_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-018-1829-0"},{"key":"e_1_2_6_269_1","unstructured":"International Dermatology Outcome Measures (IDEOM). Available at:http:\/\/dermoutcomes.org\/index.html(last accessed 30 June 2020)."},{"key":"e_1_2_6_270_1","unstructured":"Cochrane Skin.Core Outcome Set Initiative (COUSIN). Available athttp:\/\/cs\u2010cousin.org\/(last accessed 30 June 2020)."},{"key":"e_1_2_6_271_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.320"},{"key":"e_1_2_6_272_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.1165"},{"key":"e_1_2_6_273_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14475"},{"key":"e_1_2_6_274_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19030"},{"key":"e_1_2_6_275_1","unstructured":"Acne Core Outcomes Research Network (ACORN). Available at:https:\/\/sites.psu.edu\/acnecoreoutcomes\/(last accessed 30 June 2020)."},{"key":"e_1_2_6_276_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.034322"},{"key":"e_1_2_6_277_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.02.018"},{"key":"e_1_2_6_278_1","doi-asserted-by":"publisher","DOI":"10.4137\/HSI.S11093"},{"key":"e_1_2_6_279_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-4-79"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.19675","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.19675","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.19675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T02:53:47Z","timestamp":1697079227000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/185\/1\/36\/6600221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,28]]},"references-count":278,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1111\/bjd.19675"],"URL":"https:\/\/doi.org\/10.1111\/bjd.19675","archive":["Portico"],"relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,28]]},"assertion":[{"value":"2020-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}